Evidence map›Paper›PMID 33785835›Full record

ArticleScientific reports2021

In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway.

Tobias Ocklenburg, Fabian Neumann, Alexandra Wolf, Julia Vogel, Kirsten Göpelt, Melanie Baumann, Jennifer Baumann, Philip Kranz, Eric Metzen, Ulf Brockmeier

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Tobias Ocklenburg *Institut Für Physiologie, Universität Duisburg-Essen, Duisburg, Germany.
Fabian Neumann *Institut Für Physiologie, Universität Duisburg-Essen, Duisburg, Germany.
Alexandra WolfInstitut Für Physiologie, Universität Duisburg-Essen, Duisburg, Germany.
Julia VogelInstitut Für Physiologie, Universität Duisburg-Essen, Duisburg, Germany.
Kirsten GöpeltInstitut Für Physiologie, Universität Duisburg-Essen, Duisburg, Germany.
Melanie BaumannInstitut Für Physiologie, Universität Duisburg-Essen, Duisburg, Germany.
Jennifer BaumannInstitut Für Physiologie, Universität Duisburg-Essen, Duisburg, Germany.
Philip KranzInstitut Für Physiologie, Universität Duisburg-Essen, Duisburg, Germany.
Eric Metzen *Institut Für Physiologie, Universität Duisburg-Essen, Duisburg, Germany.
Ulf Brockmeier *Department of Neurology, University Hospital Essen, Essen, Germany. ulf.brockmeier@uni-due.de.
University of Duisburg-Essen · DEEssen University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The disulfide isomerase ERp57, originally found in the endoplasmic reticulum, is located in multiple cellular compartments, participates in diverse cell functions and interacts with a huge network of binding partners. It was recently suggested as an attractive new target for cancer therapy due to its critical role in tumor cell proliferation. Since a major bottleneck in cancer treatment is the occurrence of hypoxic areas in solid tumors, the role of ERp57 in cell growth was tested under oxygen depletion in the colorectal cancer cell line HCT116. We observed a severe growth inhibition when ERp57 was knocked down in hypoxia (1% O

Indexed as

Tumor HypoxiaApoptosisCell Cycle ProteinsCell ProliferationColonic NeoplasmsGene DeletionGene Expression Regulation, NeoplasticGene Knockdown TechniquesHCT116 CellsHumansOxygenPolo-Like Kinase 1Protein Disulfide-IsomerasesProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktCell Cycle ProteinsMYC protein, humanOxygenPDIA3 protein, humanPolo-Like Kinase 1Protein Disulfide-IsomerasesProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-myc

Identifiers

PMID33785835
PMCPMC8009878
OpenAlexW3146843964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.